Share on StockTwits

Cellular Biomedicine Group (NASDAQ:CBMG) CFO Tony Liu acquired 100,000 shares of the company’s stock in a transaction that occurred on Thursday, May 22nd. The shares were purchased at an average price of $5.00 per share, for a total transaction of $500,000.00. Following the acquisition, the chief financial officer now directly owns 100,000 shares in the company, valued at approximately $500,000. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Cellular Biomedicine Group (NASDAQ:CBMG) traded down 1.77% on Friday, hitting $5.00. 609 shares of the company’s stock traded hands. Cellular Biomedicine Group has a one year low of $4.24 and a one year high of $7.40. The stock has a 50-day moving average of $5.41 and a 200-day moving average of $5.33. The company’s market cap is $37.8 million.

Cellular Biomedicine Group, Inc develops cell therapies for the treatment of certain degenerative diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.